Agfa and Mitra form joint venture

Article

PACS developers Agfa of Mortsel, Belgium, and Mitra of Waterloo, Ontario, have formed a joint-venture company called Impax Technology to develop and sell PACS software based on Agfa’s Impax product line. The new company will be headed by Mitra chief

PACS developers Agfa of Mortsel, Belgium, and Mitra of Waterloo, Ontario, have formed a joint-venture company called Impax Technology to develop and sell PACS software based on Agfa’s Impax product line. The new company will be headed by Mitra chief executive Eric Peterson and will also sell Impax software to other companies.

Agfa has become the industry’s leading PACS company thanks largely to the Impax software, which Mitra developed for Agfa. The companies have been in discussions for the last several months about restructuring their eight-year relationship. The joint-venture deal allows Agfa to maintain access to the Impax software while creating a new pool of potential OEM customers for Mitra. Impax Technology will be based in Waterloo.

Recent Videos
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.